Literature DB >> 6453542

Enterococcal superinfection and colonization after therapy with moxalactam, a new broad-spectrum antibiotic.

V L Yu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6453542     DOI： 10.7326/0003-4819-94-6-784

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  50 in total

1.  Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients.

Authors:  C J Donskey; T K Chowdhry; M T Hecker; C K Hoyen; J A Hanrahan; A M Hujer; R A Hutton-Thomas; C C Whalen; R A Bonomo; L B Rice
Journal:  N Engl J Med       Date:  2000-12-28       Impact factor: 91.245

2.  Therapeutic effects of cefpirome (HR 810) on experimental mixed infections with Enterococcus faecalis and Escherichia coli in mice.

Authors:  S Arai; S Hayashi
Journal:  Infection       Date:  1990 May-Jun       Impact factor: 3.553

Review 3.  Pathogenicity of the enterococcus in surgical infections.

Authors:  P S Barie; N V Christou; E P Dellinger; W R Rout; H H Stone; J P Waymack
Journal:  Ann Surg       Date:  1990-08       Impact factor: 12.969

4.  Ceftazidime versus tobramycin-ticarcillin in the treatment of pneumonia and bacteremia.

Authors:  L A Cone; D R Woodard; D S Stoltzman; R G Byrd
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

5.  Respiratory superinfections after the use of third-generation cephem antibiotics.

Authors:  A Saito; K Mori; Y Shigeno; K Yamaguchi; K Hara
Journal:  Infection       Date:  1985       Impact factor: 3.553

6.  A review of the use of cefotaxime in the treatment of skin and skin structure infections, with special reference to gram-positive pathogens.

Authors:  P H Karakusis; G M Trenholme; S Levin
Journal:  Infection       Date:  1985       Impact factor: 3.553

7.  Impact of cefotaxime on the fecal flora in children.

Authors:  N Lambert-Zechovsky; E Bingen; Y Aujard; H Mathieu
Journal:  Infection       Date:  1985       Impact factor: 3.553

8.  Clinical experience with cefotaxime for the therapy of bacteremias due to gram-positive organisms.

Authors:  C J Schleupner
Journal:  Infection       Date:  1985       Impact factor: 3.553

Review 9.  Adverse reactions and interactions with newer cephalosporin and cephamycin antibiotics.

Authors:  S R Norrby
Journal:  Med Toxicol       Date:  1986 Jan-Feb

10.  Double-blind, prospective, multicenter trial comparing ceftazidime with moxalactam in the treatment of serious gram-negative infections.

Authors:  M Joshi; W C Anthony; J H Tenney; G L Drusano; E S Caplan; H C Standiford; A Henson; J W Warren
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.